Dosing and uses of RA (resorcinol)
Adult dosage forms and strengths
Resorcinol was discontinued and is no longer available
Pediatric dosage forms and strengths
Resorcinol was discontinued and is no longer available
RA (resorcinol) adverse (side) effects
Frequency not defined
Erythema
Excessive desquamation
Skin irritation/inflammation
Warnings
Contraindications
Hypersensitivity
Existing skin rash or irritation
Cautions
External use only
Discontinue if excessive skin irritation develops
Pregnancy and lactation
Pregnancy category: C
Lactation: insufficient data; drug absorbed through intact & broken skin
Pregnant or breastfeeding patients should seek advice of health professional before using OTC drugs
Pregnancy categories
A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.
C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.
D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.
X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.
NA: Information not available.
Pharmacology of RA (resorcinol)
Mechanism of action
Keratolytic agent
